| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr4_0190900 | Intergenic-Intergenic | chr4:153332889-153456566 | chr4:152411737-152535414 | 567 nt | 0.6032 |
| hsa_chr4_0191000 | Intergenic-Intergenic | chr4:153333358-153333642 | chr4:152412206-152412490 | 285 nt | 0.2842 |
| hsa_FBXW7_0009100 | Intron-Intron | chr4:153339867-153373739 | chr4:152418715-152452587 | 250 nt | 0.2600 |
| hsa_FBXW7_0009200 | Intron-Intron | chr4:153340821-153341119 | chr4:152419669-152419967 | 299 nt | 0.3478 |
| hsa_FBXW7_0009300 | Intron-Intron | chr4:153340982-153362411 | chr4:152419830-152441259 | 250 nt | 0.3040 |
| hsa_FBXW7_0009400 | Intron-Intron | chr4:153340982-153391140 | chr4:152419830-152469988 | 186 nt | 0.3710 |
| hsa_FBXW7_0009500 | Intron-Intron | chr4:153348322-153348711 | chr4:152427170-152427559 | 204 nt | 0.3725 |
| hsa_FBXW7_0009600 | Intron-Intron | chr4:153348557-153391140 | chr4:152427405-152469988 | 203 nt | 0.3793 |
| hsa_FBXW7_0009700 | Intron-Intron | chr4:153348557-153403825 | chr4:152427405-152482673 | 155 nt | 0.3871 |
| hsa_FBXW7_0009800 | Intron-Intron | chr4:153350265-153434123 | chr4:152429113-152512971 | 250 nt | 0.4240 |
A study in human brain cancer demonstrated that the circFBXW7 functions as a tumor suppressor, where its expression inhibits cell progression, migration, and tumor formation [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. Further research confirmed its coding potential, showing the translated peptide FBXW7-185aa reduces the half-life of c-Myc and inhibits cell cycle progression [Sema Misir et al. DOI:10.1038/s41418-022-00948-7]. The peptide FBXW7-185aa, which originates from the circFBXW7, inhibits cell cycle progression [Misir et al. DOI:10.1038/s41418-022-00948-7].